Literature DB >> 25207708

Isolation and phenotypic characterization of cancer stem like cells from nasopharyngeal carcinoma.

Y Wang1, G-H Zhang1, S-L Li1.   

Abstract

INTRODUCTION: Recent studies reported that cancer stem cells (CSCs) are responsible for treatment failure and tumor recurrence. CSCs have been isolated and characterized in several solid tumors. However, the information regarding the CSCs from nasopharyngeal carcinoma (NPC) is very less. Therefore, in the current study we aimed to isolate and characterize the cancer stem like SP cells from NPC.
METHODS: We have used FACS based Hoechst 33342 dye exclusion technique to identify the cancer stem like SP cells from NPC. The FACS sorted SP cells are further subjected to drug resistance assay, clonogenic formation assay and immunocytochemistry analysis for the expression of CD44 and ABCG2.
RESULTS: We have identified 3.9% of cancer stem like SP cells from NPC. Upon treatment with verapamil, the percentage of SP cells was reduced to 0.9%. The FACS sorted SP cells showed enhanced expression of CD44 and ABCG2. Further, these SP cells are highly resistant to multi-drugs and high potent of sphere formation when compared to the non-SP cells.
CONCLUSIONS: Our data clearly suggest that presence of cancer stem like SP cells from nasopharyngeal carcinoma might responsible for chemotherapeutic drug resistance, tumor recurrence and invasion. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25207708     DOI: 10.1055/s-0034-1382077

Source DB:  PubMed          Journal:  Drug Res (Stuttg)        ISSN: 2194-9379


  3 in total

1.  Sp1 is over-expressed in nasopharyngeal cancer and is a poor prognostic indicator for patients receiving radiotherapy.

Authors:  Jun Wang; Min Kang; Yu-Tao Qin; Zhu-Xin Wei; Jing-Jian Xiao; Ren-Sheng Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.

Authors:  Lin Kong; Jing Gao; Jiyi Hu; Weixu Hu; Xiyin Guan; Rong Lu; Jiade J Lu
Journal:  Chin J Cancer       Date:  2016-12-22

3.  Salvage Intensity-Modulated Radiation Therapy (IMRT) for Locally Recurrent Nasopharyngeal Cancer after Definitive IMRT: A Novel Scenario of the Modern Era.

Authors:  Lin Kong; Lei Wang; Chunying Shen; Chaosu Hu; Lei Wang; Jiade J Lu
Journal:  Sci Rep       Date:  2016-09-12       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.